Insight Molecular Diagnostics (IMDX) Change in Acquisitions & Divestments (2015 - 2017)
Insight Molecular Diagnostics (IMDX) posted Change in Acquisitions & Divestments of $432000.0 for Q2 2017, down 13.94% sequentially from $502000.0 in Q1 2017.
Insight Molecular Diagnostics (IMDX) Change in Acquisitions & Divestments (2015 - 2017) Analysis & Trends
Insight Molecular Diagnostics has reported Change in Acquisitions & Divestments for 2 years, with the latest figure at $432000.0 in Q2 2017.
- Quarterly Change in Acquisitions & Divestments changed N/A year-over-year to $432000.0 in Q2 2017, while the trailing twelve-month figure through Dec 2017 was $934000.0 (changed N/A YoY) and the FY2023 annual result came in at $367000.0, changed N/A from the prior year.
- Change in Acquisitions & Divestments fell to $432000.0 in Q2 2017 per IMDX's latest filing, from $502000.0 in the prior quarter.
- Over five years, Change in Acquisitions & Divestments peaked at $771000.0 in Q4 2015 and troughed at $432000.0 in Q2 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn |
| 10 | Insight Molecular Diagnostics | 158.03 Mn | 139.50 Mn | 157,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | 432,000.00 |
| Jun 30, 2017 | 432,000.00 |
| Mar 31, 2017 | 502,000.00 |
| Mar 31, 2017 | 502,000.00 |
| Dec 31, 2015 | 771,000.00 |
| Dec 31, 2015 | 771,000.00 |